Coverage / TRIB / Trade Card

TRIB

Trinity Biotech PLC

SPECULATIVE BUY 2026-08-08 Data 35 days old USD 12.43 Healthcare - Medical - Diagnostics & ResearchREDUCE ZONE
ACTIONABLEMethodology gates passed
49

Position levels

Currenttoday
USD 12.43
Buy <=wait / entry
USD 7.00
Trim >=take some off
USD 11.00
Thesis breakThe investment thesis is invalidated by a disclosed dilutive equity raise priced...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case16%100 / 10016.0
Base case48%62 / 10029.8
Bear case36%10 / 1003.6
Weighted conviction49 / 100 - SPECULATIVE BUY

Top risks

  • No OEM integrations, named supply agreements or government contracts evidenced
  • Q1 2026 EPS beat of $2.40 but TTM EPS remains deeply negative at -60.31
  • 1-for-30 reverse ADS split effective July 2026 to meet Nasdaq bid price rules
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.